Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2397-768X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies ; volume:6 ; number:1 ; day:23 ; month:10 ; year:2022 ; pages:1-17 ; date:12.2022
npj precision oncology ; 6, Heft 1 (23.10.2022), 1-17, 12.2022

Creator
Lidsky, Michael E.
Wang, Zechen
Lu, Min
Liu, Annie
Hsu, S. David
McCall, Shannon J.
Sheng, Zhecheng
Granek, Joshua A.
Owzar, Kouros
Anderson, Karen S.
Wood, Kris C.
Contributor
SpringerLink (Online service)

DOI
10.1038/s41698-022-00320-5
URN
urn:nbn:de:101:1-2023010621124182820937
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Lidsky, Michael E.
  • Wang, Zechen
  • Lu, Min
  • Liu, Annie
  • Hsu, S. David
  • McCall, Shannon J.
  • Sheng, Zhecheng
  • Granek, Joshua A.
  • Owzar, Kouros
  • Anderson, Karen S.
  • Wood, Kris C.
  • SpringerLink (Online service)

Other Objects (12)

Transarterial Therapies for the Treatment of Intrahepatic Cholangiocarcinoma

Transarterial Therapies for the Treatment of Intrahepatic Cholangiocarcinoma

Leveraging weak complementary labels enhances semantic segmentation of hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Leveraging weak complementary labels enhances semantic segmentation of hepatocellular carcinoma and intrahepatic cholangiocarcinoma

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma

Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma

Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma

The focus clinical research in intrahepatic cholangiocarcinoma

The focus clinical research in intrahepatic cholangiocarcinoma

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma

Prognostic factors in patients with intrahepatic cholangiocarcinoma

Prognostic factors in patients with intrahepatic cholangiocarcinoma

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice

Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary

Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary

Is Lymphadenectomy Reasonable for Elderly Intrahepatic Cholangiocarcinoma Patients?

Is Lymphadenectomy Reasonable for Elderly Intrahepatic Cholangiocarcinoma Patients?

Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma

Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma

Related objects